Abstract:Summary Fructose is a monosaccharide,which is greatly sweeter than glucose and sucrose.In recent years,high fructose corn syrup has been widely used in beverages and food industry globally.However,the effect of fructose on human health has received much attention in current years.In this review,we mainly discussed the food source, absorption and metabolism of fructose,relationship between fructose and metabolic disorders,and recommendation intake of total sugar. Crystalline fructose is dried,ground,and highly pure.Fructose is found in most fruits and vegetables either as a monosaccharide or as a unit of sucrose.The ratio of fructose to glucose in most natural food is approximately 1∶1 . Fructose has the lowest glycemic index of all natural sugars.High-fructose corn syrup (HFCS) is a mixture of fructose and glucose,which is widely used in food industry,added into soft drinks and baked foods for its palatability and good taste.HFCS-42,HFCS-55 and HFCS-90 are three kinds of HFCS,and the number for each HFCS represents the percentage of fructose in the syrup.Free fructose is absorbed directly by intestine via facilitated transport involving GULT5 transport proteins.Unabsorbed fructose in intestine can cause abdominal symptoms such as diarrhea and abdominal pain.When fructose exists in a 1∶1 ratio with glucose,it can be absorbed mostly.Unlike glucose,fructose can be metabolized in liver,where it can be partially converted into glucose,and mostly metabolized to fatty acid, and the latter can be synthesized into triacylglycerol. Fructose is firstly metabolized into fructose 1-phosphate by fructose to kinase referred to as fructolysis. Unlike glycolysis, in fructolysis the triose glyceraldehyde lacks a phosphate group.Fructose 1-phosphate then is hydrolyzed by aldose B to form dihydroxy acetone phosphate and glyceraldehyde.DHAP can either be isomerized to glyceraldehyde 3-phosphate by triosephosphate isomersae or reduced to glycerol 3-phosphate by glycerol 3-phosphate dehydrogenase. The glyceraldehyde produced may also be converted to glyceraldehyde 3-phosphate by glyceraldehyde kinase or further converted to glycerol 3-phosphate by glycerol 3-phosphate dehydrogenase.The metabolism of fructose yields intermediates in the gluconeogenic pathway leading to glycogen synthesis as well as fatty acid and triglyceride synthesis.Triacylglycerol can be accumulated in liver to cause non-alcohol fatty liver and insulin resistance in liver. Triglycerides are incorporated into very-low-density lipoproteins,which are released from the liver destined toward peripheral tissues for storage in both fat and muscle cells.Then,triacylglycerol can also be transported to other organs and tissues to increase the risk of insulin resistance,obesity and cardiovascular disease. Based on the available evidence,WHO recommends a reduced intake of free sugars throughout the life to limit free sugars intake to less than 10% of total energy intake.WHO suggests a further reduction of the intake of free sugars to below 5% of total energy intake. In conclusion,there exits a relationship between fructose and non-alcohol fatty liver,obesity,cardiovascular disease and insulin resistance.Therefore,fructose should be applied in an appropriate way or it will exert a detrimental influence on health.It is reasonable to pay more attention on reducing fructose intake.

Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials

Effect of Important Food Sources of Fructose-Containing Sugars on Inflammatory Biomarkers: A Systematic Review and Meta-Analysis of Controlled Feeding Trials

Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies

Fructose-containing food sources and blood pressure: A systematic review and meta-analysis of controlled feeding trials

Important Food Sources of Fructose-Containing Sugars and Blood Pressure: A Systematic Review and Meta-Analysis of Controlled Trials

Different dietary carbohydrate component intakes and long-term outcomes in patients with NAFLD: results of longitudinal analysis from the UK Biobank

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease

Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review

Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis

Fructose Intake From Fruit Juice and Sugar-Sweetened Beverages Is Associated With Higher Intrahepatic Lipid Content: The Maastricht Study.

Fatty Acid and Non-Alcoholic Fatty Liver Disease: Meta-analyses of Case-Control and Randomized Controlled Trials.

Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease

Sugar-sweetened beverages, low/no-calorie beverages, fruit juice and non-alcoholic fatty liver disease defined by fatty liver index: the SWEET project

Fructose-containing sugars, blood pressure, and cardiometabolic risk: a critical review

Fasting Serum Fructose is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease: A Prospective Study

Absorption and Metabolism of Fructose and Its Relationship with Human Health

Dietary carbohydrates and fats in nonalcoholic fatty liver disease

Systematic Review and Meta-analysis: The Role of Diet in the Development of Nonalcoholic Fatty Liver Disease

Association of Sugar-Sweetened Beverages, Low/No-Calorie Beverages and Fruit Juice Intakes with Non-alcoholic Fatty Liver Disease: The SWEET Project

Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease

The effect of low-fructose diet on anthropometric and metabolic factors: A systematic review and meta-analysis